Scientific Industries Inc Quick Ratio (SCND) starting from the second quarter 2026 to second quarter 2025, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket
 


Scientific Industries Inc   (SCND)

Scientific Industries Inc 's Quick Ratio

SCND's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


Scientific Industries Inc 's Cash & cash equivalent grew by % in the Q2 2026 sequentially, faster than Current Liabilities, this led to improvement in Scientific Industries Inc 's Quick Ratio to 4.92, above Scientific Industries Inc average Quick Ratio.

Within Laboratory Analytical Instruments industry 4 other companies have achieved higher Quick Ratio than Scientific Industries Inc in second quarter 2026. While total ranking remained the same in the Q2 2026 compared to the first quarter 2026 at no. .

Explain Quick Ratio?
How much Cash & cash equivalents SCND´s has?
What are SCND´s Current Liabilities?




SCND Quick Ratio (Jun 30 2026)
Q2
(Mar 31 2026)
Q1
(Dec 31 2025)
Q4
(Sep 30 2025)
Q3
(Jun 30 2025)
Q2
Y / Y Current Liabilities Change -5.53 % -32.25 % -22.76 % -3.54 % -4.4 %
Y / Y Cash & cash equivalent Change - - - - -
Quick Ratio MRQ 4.92 - - - -
SCND's Total Ranking # # # # #
Seq. Current Liabilities Change 10.88 % 7.09 % -13.14 % -8.4 % -20.48 %
Seq. Cash & cash equivalent Change - - - - -



Quick Ratio second quarter 2026 Company Ranking
Within: No.
Laboratory Analytical Instruments Industry # 5
Healthcare Sector # 307
Overall Market # 819


Quick Ratio Statistics
High Average Low
6.15 2.27 0.09
(Sep 30 2021)   (Dec 31 2017)




Financial Statements
Scientific Industries Inc 's Current Liabilities $ 2 Millions Visit SCND's Balance sheet
Scientific Industries Inc 's Cash & cash equivalent $ 8 Millions Visit SCND's Balance sheet
Source of SCND's Sales Visit SCND's Sales by Geography


Cumulative Scientific Industries Inc 's Quick Ratio

SCND's Quick Ratio for the trailling 12 Months

SCND Quick Ratio

(Jun 30 2026)
12 Months
(Mar 31 2026)
12 Months
(Dec 31 2025)
12 Months
(Sep 30 2025)
12 Months
(Jun 30 2025)
12 Months
Y / Y Current Liabilities TTM Growth -17.2 % -16.8 % -6.27 % -1.97 % -8.39 %
Y / Y Cash & cash equivalent TTM Growth - - - - -
Quick Ratio TTM 1.32 - - - -
Total Ranking TTM #
Seq. Current Liabilities TTM Growth -1.55 % -10.22 % -5.58 % -0.79 % -1.08 %
Seq. Cash & cash equivalent TTM Growth - - - - -


On the trailing twelve months basis SCND Cash & cash equivalent remained unchanged by % in Q2 2026 year on year, while Current Liabilities remained unchanged to $2 millions, this led to